Guide Genetics is committed to achieving Net Zero emissions by 2050, aligning with sustainability goals in the healthcare sector. As a provider of AI-driven digital health solutions, we recognize the importance of minimizing our environmental footprint while supporting NHS efforts to enhance patient care efficiency.
Guide Genetics operates primarily as a cloud-based, digital-first company, meaning our direct emissions (Scope 1 and 2) are minimal. However, we acknowledge the impact of indirect emissions (Scope 3) from cloud computing, remote work infrastructure, and supply chain operations.
These are estimates made by Guide Genetics about its activities over the past years.
Scope | Category | Commentary | Estimated Emissions (tCO2e) |
---|---|---|---|
1 | Direct Fuel Combustion | No direct emissions | 0 |
2 | Office Electricity & Heating | Slight increase in office energy usage – 500 sq. ft. | 2.7 |
3 | Business Travel – Flights, Transport | Minor increase in travel for conferences, meetings | 3.2 |
3 | Cloud Computing & IT Infrastructure | Increased AI tool development and cloud usage | 1.2 |
3 | Other – Employee Commuting, Miscellaneous Supply Chain | More office visits, minor increases in supply chain activity | 0.6 |
Total Emissions Reduction | 7.7 tCO2e |
In line with our commitment to Net Zero, Guide Genetics has established the following reduction targets:
We project that carbon emissions will decrease over the next five years to 6.2 tCO2e by 2029, reflecting a 20% reduction from our 2024 baseline emissions of 7.7 tCO2e.
Would you like to add any specific initiatives that contribute to these reductions, such as carbon offset programs or sustainable supply chain policies?
Guide Genetics has implemented several sustainability initiatives, including:
To further our commitment to carbon reduction, we plan to:
This Carbon Reduction Plan has been completed in accordance with PPN 06/21 and associated GHG Reporting Protocol standards.